Veradermics Incorporated MANE
—
116.57
0.85
0.73%
as of 25 Sep
- Market cap
- $5.0B
- P/E
- 0.0×
Follow MANE
Insider Buys
alert about insiders buying in the last 12 month
| Dec '24 | Dec '25 | |
|---|---|---|
Current Ratio |
11.77 | 16.66 |
Net Debt/EBITDA |
1.98 | 1.96 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
— | 0.00 |
Operating CF/Net income |
0.87 | 0.86 |
Capex/Depreciation |
— | 0.00 |
Interest Coverage |
0.00 | 0.00 |
| 0.00% | 98.38% | |
| 0.00% | (80.11%) | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
(53.73%) | (58.15%) |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% |
Free Cash Flow per Share |
(32.14) | (96.14) |
Cash per Share |
72.03 | 190.42 |
Shareholders Equity per Share |
(65.78) | (162.43) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(65.78) | (162.43) |
Free Cash Flow |
(23.69) | (71.63) |
Working Capital |
50.82 | 143.34 |
Capital Expenditures |
— | (0.02) |
Net Current Asset Value |
(48.48) | (121.14) |
| Other line items | ||
Quick Ratio |
11.25 | 15.50 |
Depreciation/Fixed assets |
— | 0.00 |
Cash ROIC |
(514.51%) | (343.55%) |
Accounts Payable Turnover |
— | 0.00 |
Average Days of Payables |
0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(32.14) | (96.11) |
Capex per Share |
0.00 | (0.03) |
Average Payables |
— | 2.19 |
Average Assets |
— | 104.08 |
Average Common Equity |
— | (84.75) |
Capex to Sales |
— | 0.00 |
Net Profit Margin |
0.00% | 0.00% |
Columns are period end dates